Status: current, Defined. Date: 30-Apr 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3572221000168114 | Vascalace (ramipril 1.25 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3572231000168112 | Vascalace 1.25 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vascalace 1.25 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Vascalace 1.25 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Vascalace 1.25 mg tablet | Is a | Vascalace | true | Inferred relationship | Some | ||
| Vascalace 1.25 mg tablet | Is a | ramipril 1.25 mg tablet | true | Inferred relationship | Some | ||
| Vascalace 1.25 mg tablet | has manufactured dose form | uncoated tablet | false | Inferred relationship | Some | ||
| Vascalace 1.25 mg tablet | has intended active ingredient | ramipril | true | Inferred relationship | Some | 1319154624 | |
| Vascalace 1.25 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1319154625 | |
| Vascalace 1.25 mg tablet | has Australian BoSS | ramipril | true | Inferred relationship | Some | 1319154624 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Vascalace 1.25 mg tablet, 30, bottle | has TPUU | True | Vascalace 1.25 mg tablet | Inferred relationship | Some | 1 |
| Vascalace 1.25 mg tablet, 30, blister pack | has TPUU | True | Vascalace 1.25 mg tablet | Inferred relationship | Some | 1 |
| Vascalace 1.25 mg tablet, 30 | has TPUU | True | Vascalace 1.25 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR